These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 15114951)
1. Reaching Every District (RED) approach: a way to improve immunization performance. Vandelaer J; Bilous J; Nshimirimana D Bull World Health Organ; 2008 Mar; 86(3):A-B. PubMed ID: 18368190 [No Abstract] [Full Text] [Related]
2. Measles Virus Infection Among Vaccinated and Unvaccinated Children in Nigeria. Faneye AO; Adeniji JA; Olusola BA; Motayo BO; Akintunde GB Viral Immunol; 2015; 28(6):304-8. PubMed ID: 26102341 [TBL] [Abstract][Full Text] [Related]
3. Immunization of HIV infected children. Chandra J; Yadav D Indian J Pediatr; 2012 Dec; 79(12):1634-41. PubMed ID: 22323103 [TBL] [Abstract][Full Text] [Related]
4. Measles outbreak in Africa--is there a link to the HIV-1 epidemic? Nilsson A; Chiodi F PLoS Pathog; 2011 Feb; 7(2):e1001241. PubMed ID: 21347342 [No Abstract] [Full Text] [Related]
5. Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months. Knuf M; Zepp F; Meyer CU; Habermehl P; Maurer L; Burow HM; Behre U; Janssens M; Willems P; Bisanz H; Vetter V; Schmidt-Ott R Eur J Pediatr; 2010 Aug; 169(8):925-33. PubMed ID: 20148263 [TBL] [Abstract][Full Text] [Related]
6. Varicella vaccination in Europe - taking the practical approach. Bonanni P; Breuer J; Gershon A; Gershon M; Hryniewicz W; Papaevangelou V; Rentier B; Rümke H; Sadzot-Delvaux C; Senterre J; Weil-Olivier C; Wutzler P BMC Med; 2009 May; 7():26. PubMed ID: 19476611 [TBL] [Abstract][Full Text] [Related]
7. Measles control and the prospect of eradication. Moss WJ Curr Top Microbiol Immunol; 2009; 330():173-89. PubMed ID: 19203110 [TBL] [Abstract][Full Text] [Related]
9. Immunization in patients with HIV infection: are practical recommendations possible? Eley B Drugs; 2008; 68(11):1473-81. PubMed ID: 18627205 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. Zepp F; Behre U; Kindler K; Laakmann KH; Pankow-Culot H; Mannhardt-Laakmann W; Beckers F; Descamps D; Willems P Eur J Pediatr; 2007 Aug; 166(8):857-64. PubMed ID: 17541639 [TBL] [Abstract][Full Text] [Related]
11. [Ambitious measles vaccination program in Vietnam]. Björklund J; Strand M; Blennow M Lakartidningen; 2006 Apr 26-May 2; 103(17):1325-7. PubMed ID: 16708862 [No Abstract] [Full Text] [Related]
12. Measles vaccines: WHO position paper, April 2017 - Recommendations. World Health Organization Vaccine; 2019 Jan; 37(2):219-222. PubMed ID: 28760612 [TBL] [Abstract][Full Text] [Related]